DE3925109C2 - - Google Patents

Info

Publication number
DE3925109C2
DE3925109C2 DE3925109A DE3925109A DE3925109C2 DE 3925109 C2 DE3925109 C2 DE 3925109C2 DE 3925109 A DE3925109 A DE 3925109A DE 3925109 A DE3925109 A DE 3925109A DE 3925109 C2 DE3925109 C2 DE 3925109C2
Authority
DE
Germany
Prior art keywords
extract
plant
mouse
extract according
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3925109A
Other languages
German (de)
English (en)
Other versions
DE3925109A1 (de
Inventor
Klaus Prof. Dr. Eichmann
Manuel Dr. 7800 Freiburg De Modolell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE3925109A priority Critical patent/DE3925109A1/de
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority to AT90910726T priority patent/ATE112489T1/de
Priority to CA002035031A priority patent/CA2035031A1/en
Priority to PCT/EP1990/001231 priority patent/WO1991001741A1/en
Priority to ES90910726T priority patent/ES2061053T3/es
Priority to EP90910726A priority patent/EP0436690B1/en
Priority to AU60736/90A priority patent/AU635553B2/en
Priority to JP2510688A priority patent/JPH04500820A/ja
Priority to DE69013134T priority patent/DE69013134T2/de
Priority to US07/659,313 priority patent/US5256416A/en
Publication of DE3925109A1 publication Critical patent/DE3925109A1/de
Application granted granted Critical
Publication of DE3925109C2 publication Critical patent/DE3925109C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3925109A 1989-07-28 1989-07-28 Extrakte der pflanze acanthospermum hispidum Granted DE3925109A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE3925109A DE3925109A1 (de) 1989-07-28 1989-07-28 Extrakte der pflanze acanthospermum hispidum
CA002035031A CA2035031A1 (en) 1989-07-28 1990-07-27 Extracts of the acanthospermum hispidum plant
PCT/EP1990/001231 WO1991001741A1 (en) 1989-07-28 1990-07-27 Extracts of the acanthospermum hispidum plant
ES90910726T ES2061053T3 (es) 1989-07-28 1990-07-27 Extractos de la planta acantospermum hispidum.
AT90910726T ATE112489T1 (de) 1989-07-28 1990-07-27 Extrakte von acanthospermum hispidum-pflanzen.
EP90910726A EP0436690B1 (en) 1989-07-28 1990-07-27 Extracts of the acanthospermum hispidum plant
AU60736/90A AU635553B2 (en) 1989-07-28 1990-07-27 Extracts of the acanthospermum hispidum plant
JP2510688A JPH04500820A (ja) 1989-07-28 1990-07-27 植物アカンソスペルマム・ヒスピダムの抽出物
DE69013134T DE69013134T2 (de) 1989-07-28 1990-07-27 Extrakte von acanthospermum hispidum-pflanzen.
US07/659,313 US5256416A (en) 1989-07-28 1990-07-27 Extracts of the Acanthospermum hispidum plant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3925109A DE3925109A1 (de) 1989-07-28 1989-07-28 Extrakte der pflanze acanthospermum hispidum

Publications (2)

Publication Number Publication Date
DE3925109A1 DE3925109A1 (de) 1991-01-31
DE3925109C2 true DE3925109C2 (cg-RX-API-DMAC10.html) 1992-10-15

Family

ID=6386098

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3925109A Granted DE3925109A1 (de) 1989-07-28 1989-07-28 Extrakte der pflanze acanthospermum hispidum
DE69013134T Expired - Fee Related DE69013134T2 (de) 1989-07-28 1990-07-27 Extrakte von acanthospermum hispidum-pflanzen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69013134T Expired - Fee Related DE69013134T2 (de) 1989-07-28 1990-07-27 Extrakte von acanthospermum hispidum-pflanzen.

Country Status (9)

Country Link
US (1) US5256416A (cg-RX-API-DMAC10.html)
EP (1) EP0436690B1 (cg-RX-API-DMAC10.html)
JP (1) JPH04500820A (cg-RX-API-DMAC10.html)
AT (1) ATE112489T1 (cg-RX-API-DMAC10.html)
AU (1) AU635553B2 (cg-RX-API-DMAC10.html)
CA (1) CA2035031A1 (cg-RX-API-DMAC10.html)
DE (2) DE3925109A1 (cg-RX-API-DMAC10.html)
ES (1) ES2061053T3 (cg-RX-API-DMAC10.html)
WO (1) WO1991001741A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20170119833A1 (en) * 2014-06-10 2017-05-04 Deepa Natarajan Acanthospermum hispidum composition for the treatment of cancer and methods for its manufacture
US20230060934A1 (en) * 2021-08-25 2023-03-02 Michael Wayne Dockery Botanical antiviral nutritional supplement

Also Published As

Publication number Publication date
DE69013134D1 (de) 1994-11-10
ES2061053T3 (es) 1994-12-01
WO1991001741A1 (en) 1991-02-21
ATE112489T1 (de) 1994-10-15
CA2035031A1 (en) 1991-01-29
AU635553B2 (en) 1993-03-25
JPH04500820A (ja) 1992-02-13
EP0436690B1 (en) 1994-10-05
AU6073690A (en) 1991-03-11
DE3925109A1 (de) 1991-01-31
US5256416A (en) 1993-10-26
EP0436690A1 (en) 1991-07-17
DE69013134T2 (de) 1995-02-16

Similar Documents

Publication Publication Date Title
DE3227262C2 (cg-RX-API-DMAC10.html)
DE68920019T2 (de) Aloe-zusammensetzungen und deren verwendungen.
DE3421789C2 (cg-RX-API-DMAC10.html)
DE69634530T2 (de) Antivirales mittel und verfahren zu dessen herstellung
DE4242902A1 (de) Verfahren zur Herstellung von Lektinkonzentraten aus Mistelextrakten und daraus hergestellte standardisierte Präparate zur Erhöhung der natürlichen Immunresistenz und für die Verwendung in der Tumor-Therapie
DE60124591T2 (de) Agastache rugosa extrakt mit entzündungshemmender wirkung und antiatherogener wirkung
DE3925109C2 (cg-RX-API-DMAC10.html)
EP1283047B1 (de) Methode zur herstellung einer bioaktiven substanz aus blutserum
DE3850262T2 (de) Verfahren zur herstellung einer physiologisch aktiven substanz aus samenschalen von föhren und ein gegen infektionen aktives mittel, hauptsächlich auf der basis von diesem extrakt.
Jurg et al. Antimalarial activity of some plant remedies in use in Marracuene, southern Mozambique
DE4138624C2 (cg-RX-API-DMAC10.html)
DE3787202T2 (de) Extrakte der Neriumspezies, Verfahren zu deren Herstellung und Anwendung davon.
CH650154A5 (de) Wasserloesliche, biologisch aktive fraktion aus dem interzellularen medium des knochenmarks, verfahren zu deren gewinnung und diese enthaltende pharmazeutische zubereitung.
DE3141970C2 (cg-RX-API-DMAC10.html)
DE4236346A1 (de) Wirkstoffgruppe, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE3111056A1 (de) Verfahren zur gewinnung eines heilmittels mit wirkung bei arthritis und anderen krankheiten des osteolokomotorischen systems
DE4010368C2 (cg-RX-API-DMAC10.html)
DE3123830A1 (de) "antivirussubstanz und verfahren zu ihrer herstellung"
DE69526096T2 (de) Wachstumsregulator
DE4206233C1 (en) Use of Bellis Perennis extract - for treatment and prevention of hypoxia caused by e.g. cerebral ischaemia
EP0315182B1 (de) Arzneimittel mit einem Gehalt an einer Polysaccharide enthaltenden Komponente aus Thujapflanzen als aktivem Wirkstoff
DE69902866T2 (de) Extrakte aus kuhausscheidungen mit antikrebs- und antiinflammatorischer wirksamkeit sowie verfahren zu deren herstellung
DE1617659A1 (de) Polynucleotide,welche als die Interferonerzeugung in lebenden tierischen Zellen induzierende Verbindungen wirksam sind
DE745419C (de) Verfahren zur Herstellung eines spezifischen Heilmittels gegen Hautekzeme
DE3249946C2 (de) hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK PATENT GMBH, 64293 DARMSTADT, DE

8339 Ceased/non-payment of the annual fee